Miller, D K <br/><br/>
A phase II trial of high dose epirubicin in patients with advanced breast carcinoma.  [electronic resource] 

 -  Cancer  Jan 2000 
 - 375-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0142(20000115)88:2<375::aid-cncr19>3.0.co;2-m  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Epirubicin--administration & dosage<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Treatment Outcome<br/>Ventricular Function, Left--drug effects